Medical/Pharmaceuticals

The Taiwan External Trade Development Council launches online "Anti-COVID-19 Pavilion" sharing epidemic prevention information

HANOI, Vietnam, June 24, 2020 /PRNewswire/ -- In Jun 2020, The Taiwan External Trade Development Council (TAITRA) has announced the launch of the "Taiwan Anti-COVID-19 Pavilion." The pavilion combines the work of experts from different areas, including more than 20 medical institutions and 2,000...

2020-06-24 08:00 664

IgNova Files Patent Application on Antibody Against COVID-19

VISBEK, Germany, June 24, 2020 /PRNewswire/ -- IgNova announced today that it has filed a patent application covering the use of passive immunization to control SARS-CoV-2 infection in humans. IgNova, a biopharmaceutical R&D start up, researches technology based on specific egg immunoglobulins (I...

2020-06-24 02:13 742

Dymax Introduces MD(R) 250-CTH Cationic Epoxy for Medical Device Assembly

TORRINGTON, Conn., June 23, 2020 /PRNewswire/ -- Dymax Corporation expands its range of MD® Medical Device Adhesives with the introduction of MD® 250-CTH, a new cationic epoxy. It's formulated for manufacturers that require extremely low shrinkage for lens alignment and cementing of endoscope/mic...

2020-06-23 09:30 613

Greater cfDNA Recovery May Help Accelerate Development of Cancer Liquid Biopsy Applications

HONG KONG, June 23, 2020 /PRNewswire/ -- PHASE Scientific, a high-growth biotechnology company that develops innovative sample preparation technologies, announced new findings at the American Association for Cancer Research (AACR) 2020 Virtual Annual Meeting II. The study presented by MD Anderson...

2020-06-23 09:00 648

Bendit Technologies Announces Senior Management Appointments

Richard Cappetta has been appointed Chairman of the Board and Yossi Mazel will be the new CEO TEL AVIV, Israel, June 23, 2020 /PRNewswire/ -- Bendit Technologies, an industry leader in the development of steerable microcatheters, announced today thatRichard Cappetta has been appointed as its Cha...

2020-06-23 08:00 642

ABM Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of ABM-1310 in the USA

SAN DIEGO, June 22, 2020 /PRNewswire/ -- ABM Therapeutics, a clinical-stage biopharmaceutical company developing a new generation of BRAF inhibitor, today announced that the first cancer patient has been successfully enrolled and dosed with ABM-1310 in the Phase 1 clinical trial in theUSA. ABM-13...

2020-06-22 23:00 517

New SEMI-NBMC, GE Research Project to Advance Vital Signs Monitoring of Patients During Emergency Air Transport

MILPITAS, California, June 22, 2020 /PRNewswire/ -- Nano-Bio Materials Consortium (NBMC), a SEMI Strategic Association Partner, today launched a project with GE Research to develop a medical-grade wireless patch that monitors the vital signs of medical patients during emergency air transport. Th...

2020-06-22 22:00 756

Arçelik Completes Mass Production of 5,000 Ventilators to Meet International Demand

- Arçelik, which owns Beko and Grundig, collaborated with leading Turkish businesses to produce the life-saving ventilators on a not-for-profit basis - Ventilators have been provided to countries including Brazil, Chad, Nigeria, Niger, Azerbaijan, Libya, Uzbekistan, Somalia, Dagestan and Syria - ...

2020-06-22 16:00 550

Cutting-edge Multidisciplinary Approaches to Minimally Invasive Cancer Treatment Utilizing JCI MN COLLOIDAL IODINE (R) and Possible Effect on SARS-CoV-2

TOKYO, June 22, 2020 /PRNewswire/ -- On June 10, 2020, JCI MN IODINE Co., Ltd. released the following new information regarding the therapeutic usefulness of JCI MN IODINE agents.Ryusuke Fujiki, Clinical Head and President of Fujiki Hospital, announced "minimally invasive, multidisciplinary treat...

2020-06-22 13:00 315

Kazia Presents Further Paxalisib and Cantrixil Data at AACR, Reinforcing Positive Efficacy Signals for both Drugs

SYDNEY, June  22, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to share poster presentations of interim data from the ongoing phase II study of paxalisib (formerly GDC-0084) in glioblastoma, the most com...

2020-06-22 12:39 2995

Qiming's Portfolio Company SinocellTech Lands on STAR Market

SHANGHAI, June 22, 2020 /PRNewswire/ -- Chinese biologic drug developer SinocellTech, Qiming's portfolio company, today lands on the Science and Technology Innovation Board (the STAR Market). The issue price of SinocellTech (SHSE: 688520) isCNY 25.64 per share. The stock opens at CNY 85 per share...

2020-06-22 12:20 685

Amid Turmoil, 2020 Tang Prize Laureates Strive for An Orderly New World

TAIPEI, June 22, 2020 /PRNewswire/ -- The theme of the 2020 Tang Prize, "for a world of virtue," is intended to extol the pursuit of the ultimate goodness taken up by its latest laureates who demonstrated to us the best one can achieve in the fields of environmental sustainability, medical scienc...

2020-06-22 08:09 442

Innovent Announces The Stock Exchange of Hong Kong Limited Approved the "B" Marker Removal from the Company's Stock Symbol in the HKEX

SUZHOU, China, June 22, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announc...

2020-06-22 07:40 2757

Ascentage Pharma Enters Clinical Collaboration to Evaluate the Combination of Bcl-2 and BTK Inhibitors

SUZHOU, China and ROCKVILLE, Md., June 22, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and senescence diseases, today announced a clinical collaboration with Acerta P...

2020-06-22 07:15 370

Innovent Announces the NMPA Granted Marketing Approval for BYVASDA® (Bevacizumab Biosimilar) in China

SUZHOU, China, June 19, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announc...

2020-06-19 12:20 8389

VISTA Eye Specialists collaborates with Hoya Vision Care and Vision Space Optometrists to raise awareness on Myopia Pandemic[1]

KUALA LUMPUR, Malaysia, June 19, 2020 /PRNewswire/ -- VISTA, in a collaboration with Hoya Vision Care and Vision Space Optometrists (Vision Space), will be sharing with the public, via Facebook Live Webinar on25 June 2020 8pm titled 'Addressing our Children's Sight: Controlling the progress of Sh...

2020-06-19 08:30 1340

Calypso Biotech Completes CALY-002 Clinical Batch Manufacturing

AGC Biologics produces humanized monoclonal antibody targeting IL-15 SEATTLE, June 18, 2020 /PRNewswire/ -- AGC Biologics, a global biopharmaceutical Contract Development Manufacturing Organization (CDMO), produces a GMP-grade clinical batch of CALY-002 forCalypso Biotech. The immunotherapy biot...

2020-06-18 19:00 965

Ascentage Pharma Submits Its First New Drug Application to National Medical Products Administration, for HQP1351, the First Third-Generation BCR-ABL Inhibitor in China

SUZHOU, China and ROCKVILLE, Md., June 18, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that Guangzhou Healthquest P...

2020-06-18 17:30 411

Innovent Announces First Patient Dosed in A Phase 1b/2 Clinical Trial of IBI362, a Dual GLP-1 and Glucagon Receptor Agonist, in China

SUZHOU, China, June 18, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today annou...

2020-06-18 12:00 2830

Yuyu Pharma Will Export SD BIOSENSOR COVID-19 Test Kits to the Global Market

SEOUL, South Korea, June 18, 2020 /PRNewswire/ -- Yuyu Pharma (CEO Robert Wonsang Yu, KRX 000220) and SD BIOSENSOR (CEO Hyo-Keun, Lee) entered into a Supply Agreement, where Yuyu Pharma will export COVID-19 Test Kits to the Global Market. Leveraging Yuyu Pharma's global network, the company is in...

2020-06-18 09:00 874
1234567 ... 176